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Clinical assessment of dementia
he diagnosis of Alzheimer’s disease (AD) is
essentially a two-stage process. First, a diagnosis of demen-
tia is made, the main conditions from which it should be
differentiated being delirium, depression, concomitant
physical illness, drug treatment, learning disability, the
effects of a severely impoverished environment, and the
normal memory loss that accompanies aging. Dementia
is a clinical syndrome, and determining the cause of the
syndrome is the second stage. The commonest cause is
AD, followed by vascular dementia, Lewy-body dementia,
and frontal lobe dementia. There are many so-called sec-
ondary causes of dementia, some of which are treatable. 
The clinical syndrome of dementia has three primary
expressions. First, a neuropsychological element consisting
of amnesia (loss of memory); aphasia (either a receptive
aphasia or expressive aphasia, the latter being more appar-
ent in conversation, and nominal aphasia tested by direct
questioning of naming of objects); apraxia (the inability to
carry out tasks despite intact sensory and motor nervous
systems, manifest in dementia most usually by an inability
to dress often described as putting on a shirt or coat back
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The diagnosis of Alzheimer’s disease (AD) is a 2-stage process. In stage 1, the dementia syndrome, compris-
ing neuropsychologic and neuropsychiatric components together with deficits in activities of daily living, is
differentiated on clinical grounds from a number of other conditions (delirium, concomitant physical illness,
drug treatment, normal memory loss, etc). In stage 2, the cause is determined, AD being the most common,
followed by vascular dementia, Lewy-body dementia, frontal lobe dementia, and a host of so-called sec-
ondary causes. Although a mixed Alzheimer/vascular picture is common, gradual onset of multiple cognitive
deficits is typical of AD, while abrupt onset, a fluctuating course, hypertension, and focal neurologic signs
suggest vascular dementia. In Lewy-body dementia, memory loss may not be an early feature, and fluctua-
tion can be marked by distressing psychotic symptoms and behavioral disturbance. Investigations should be
minimally invasive and relatively cheap, confined to routine blood tests, chest x-ray and/or electrocardiogram
if clinically indicated, cardiologic or neurologic referral in the presence of cerebrovascular signs, and com-
puted tomography if an intracranial lesion is suspected. Accurate diagnosis enables the clinician to outline
the disease course to the family and inform them of genetic implications. Numerous instruments for assess-
ing cognitive function, global status, psychiatric well-being, and activities of daily living are briefly reviewed.
Tto front, or the inability to use a knife and fork correctly;
and agnosia (the inability to recognize things such as one’s
own mirror reflection or a family member—remember
this is different from forgetting the name of someone). 
Second, a neuropsychiatric component with associated
symptoms such as psychiatric disturbances and behavioral
disorders, which are present in a substantial proportion of
patients. These symptoms have been described in a num-
ber of ways—noncognitive features, neuropsychiatric fea-
tures, and, more recently, behavioral and psychological
symptoms of dementia (BPSD). The commonest are
(approximate frequencies in brackets): depression (up to
66% at some point during their dementia); paranoid
ideation (30%); misidentifications (20%, usually based on
agnosia, often manifest as a failure to recognize others,
sometimes coupled with the delusional belief that people
or objects have been duplicated); hallucinations (15%,
most commonly auditory, suspect an intercurrent delir-
ium or Lewy-body dementia if persistent visual halluci-
nations are present); aggression (20%); and wandering
(20%).Third, deficits in activities of daily living. Towards
the later stages of dementia, these are manifest by obvi-
ous problems in dressing, eating, and going to the toilet
(basic activities of daily living). In the early stages, they
may manifest by a failure to wash or dress to a person’s
usual standard, and, in people living alone, self-neglect of
the diet can lead to weight loss, while neglect of house-
hold tasks lead to comments about cleanliness of the
house (instrumental activities of daily living). 
FEATURES OF DEMENTIA
￿ Neuropsychologic: amnesia, aphasia, apraxia, agnosia
￿ Neuropsychiatric: psychiatric disorders (eg, delusions,
depression, hallucinations) behavioral disturbances (eg, 
aggression, agitation)
￿ Activities of daily living (basic and instrumental)
This triad of presentation is common to all types of
dementia, the differentiation being based on the clinical
presentation, the presence of other features, and other
aspects of the history and examination.
Clinical presentation of dementia
Patients with dementia tend to come to the attention of
specialist services only when symptoms begin to inter-
fere with their lives and are affecting everyday func-
tioning. By then, the patient is often not able to provide
an accurate history and may deny there is any problem.
A history from an informant is essential. Dementia can
have an apparent sudden onset, coinciding with the
death of a spouse, a move from a familiar neighborhood,
or a foreign holiday, but such an impression may have
merely brought the condition to the notice of others or
have precipitated a decline because of a sudden change
in the environment. Support of the patient by a spouse
or other carer can minimize problems that become evi-
dent to others only after a bereavement. A thorough
history from an informant usually uncovers the truth.
Failing cognitive function can be minimized by adher-
ence to rigid routines, which are disrupted when the suf-
ferer moves away from familiar surroundings.
PRESENTATION OF DEMENTIA
￿ Often noticed by others
￿ Often precipitated by another event, eg, holiday or house
move
￿ Death of a spouse may reveal previously unnoticed 
problems
￿ Informant history essential
130
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Selected abbreviations and acronyms
ADAS Alzheimer’s Disease Assessment Scale
ADFACS Alzheimer’s Disease Functional Assessment and
Change Scale
AMTS Abbreviated Mental Test Score 
BADLS Bristol Activities of Daily Living Scale
BEHAV-AD Behavioral symptoms in Alzheimer’s disease
(scale) 
CDR Clinical Dementia Rating
CDT Clock Drawing Test
CSDD Cornell Score for Depression in Dementia
DAD Disability Assessment for Dementia
GDS Global Deterioration Scale
IDDD Interview for Deterioration in Daily living activ-
ities in Dementia
MMSE Mini-Mental State Examination 
MOUSEPAD Manchester and Oxford Universities Scale for
the Psychopathological Assessment of Dementia
NPI Neuropsychiatric Inventory
SMMSE Standardized Mini-Mental State Examination131
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Symptoms of Alzheimer's disease
The first symptoms of AD are usually cognitive in nature,
and memory impairment and disorientation in time and
place are probably the commonest manifestations. Short-
term memory is particularly impaired and the signifi-
cance of such a change is sometimes not fully appreciated
by families and others (including professionals), often
being put down to a normal age-related decline. Changes
in personality may, retrospectively, be regarded as one
of the earliest signs of dementia and are well docu-
mented in the later stages. Blessed et al
1 described eleven
types of personality change which are summarized below.
Consensus criteria for the diagnosis of Alzheimer’s dis-
ease have been published and widely validated.
2
PERSONALITY CHANGES IN DEMENTIA
￿ Increased rigidity 
￿ Increased egocentricity
￿ Impairment of regard for the feelings of others 
￿ Coarsening of affect
￿ Impairment of emotional control 
￿ Hilarity in inappropriate situations 
￿ Diminished emotional responsiveness
￿ Sexual misdemeanor 
￿ Hobbies relinquished 
￿ Diminished initiative or growing apathy 
￿ Purposeless hyperactivity 
Symptoms of vascular dementia
Differentiation between AD and vascular dementia can
be difficult because the two conditions often coexist. The
onset of vascular dementia is usually sudden and can
sometimes follow a clearly definable cerebrovascular acci-
dent. The course is usually described as a stepwise pro-
gression with episodes of confusion with fluctuations in
the degree of cognitive impairment. 
DIAGNOSTIC CRITERIA FOR DEMENTIA 
OF THE ALZHEIMER TYPE
￿ Development of multiple cognitive deficits with both:
- Memory impairment
- One or more of amnesia, apraxia, agnosia,
￿ Gradual onset of symptoms
￿ Symptoms interfere with work and social activities
￿ Absence of any other illness (systemic or cerebral) causing
the dementia
There is more lability of mood and a greater tendency
towards depression and anxiety than is generally seen in
AD. Very occasionally, small lacunar infarcts can be asso-
ciated with gradual mental deterioration without focal
signs. The patchy nature of the psychological deficits  in
contrast to the global impairment of AD is said to dis-
tinguish between the two types of dementia, with rela-
tive preservation of personality and insight in vascular
dementia. 
The key features that distinguish between AD and vas-
cular dementia were described by Hachinski
3 and made
up into a checklist from which a score (the Ischemic or
Hachinski score) is derived. The original score was based
on features of vascular dementia in a textbook of psychi-
atry and studies of the cerebral blood flow in patients
with dementia. 
FEATURES SUGGESTIVE OF VASCULAR 
DEMENTIA (NOTIONAL WEIGHTING IN BRACKETS)
￿ Abrupt onset (2)
￿ Stepwise deterioration (1)
￿ Fluctuating course (2)
￿ Nocturnal confusion (1)
￿ Preserved personality (1)
￿ Depression (1)
￿ Somatic complaints (1)
￿ Emotional incontinence (1)
￿ Hypertension (1)
￿ History of strokes (2)
￿ Associated atherosclerosis (1)
￿ Focal neurological signs (2)
￿ Focal neurological symptoms (2)
DIAGNOSTIC CRITERIA FOR VASCULAR DEMENTIA
￿ Presence of dementia
￿ Focal neurological signs and symptoms or neuroimaging 
evidence of cerebrovascular disease judged to be 
etiologically related to the dementia
￿ Symptoms not occurring in the course of delirium
Patients from the initial study group were relatively
young and more mildly affected by their illness than are
patients seen in most old-age psychiatry services. A
bimodal distribution of scores was found and suggested
that patients with a score below 4 had a dementia of the
Alzheimer type and those having a score of 7 or above a
vascular dementia. Patients scoring between 4 and 7 were
thought to have a mixed picture. The key features of vas-132
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Key features of VaD
Dementia 
definition
Probable VaD
Possible  
ADDTC Criteria
4
Global deterioration from previous
level of function sufficient to 
interfere with the patient’s life
Requires all of the following:
1. Dementia
2. Evidence of two or more strokes by
history, neurological signs, and/or 
neuroimaging, or a single stroke with a
clear temporal  relationship to the
onset of dementia
3. Evidence of at least one infarct 
outside the cerebellum by CT or Tl-
weighted MRI
1. Dementia and
2. One or more of the following:
￿ History or evidence of a single stroke
without a clear temporal relationship
to dementia onset, or
￿ Binswanger’s disease that includes all
the following:
(i) early onset of urinary 
incontinence or gait disturbance; 
(ii) vascular risk factors; 
(iii) extensive white matter changes
on neuroimaging
NINDS-AIREN Criteria
5
Impairment of memory plus at least two other areas of 
cognitive domains (not due to the physical effects of stroke
alone) sufficient to interfere with the patient’s life 
Requires all of the following:
1. Dementia
2. CVD; focal signs on examination + evidence of relevant
CVD by brain imaging (CT/MRI)
3. Relationship between the above two disorders, 
manifested by one or more of the following:
￿ dementia onset within 3 months of a stroke
￿ abrupt deterioration in cognitive functions, 
or fluctuating stepwise course
May be made in the presence of dementia and focal 
neurological signs in patients with:
1. No evidence of CVD on neuroimaging; or
2. In the absence of clear temporal relationship between
stroke and dementia; or
3. In patients with subtle onset and variable course of 
cognitive deficit and evidence of CVD
cular dementia are shown in Table I.
4-6 More recently,
the validity of using the Hachinski score to differentiate
between vascular dementias and other types of demen-
tias has been questioned. The Hachinski score has been
criticized as not being sufficiently sensitive. Moreover,
higher scores on the Hachinski do not mean that a diag-
nosis of vascular dementia is more likely, and the check-
list does not take into account results from neuroradio-
logical examinations. Infarctions are common in older
people, including those with AD, and thus a mixed pic-
ture is common. The features that have been found to
be most accurate in differentiating vascular- and
Alzheimer-type dementia include neurological signs and
symptoms, history of strokes, hypertension, and abrupt
onset.
7 There are two sets of diagnostic criteria for vas-
cular dementia and these are summarized in Table I.
Symptoms of Lewy-body dementia
Lewy-body dementia is characterized by a fluctuating
course with distressing psychotic symptoms and
marked behavioral disturbance interspersed with peri-
Table I. Key features of vascular dementia (VaD) according to the criteria of ADDTC (Alzheimer’s Disease Diagnostic and Treatment Centers)
and NIND–AIREN (National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherche et l’Enseignement
en Neurosciences). CT, computed tomography; CVD, cerebrovascular disease; MRI, magnetic resonance imaging; Tl, thallium. 
Adapted from ref 4: Amar K, Wilcock G, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing. 1996;25:51-55.133
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ods of lucidity when the degree of cognitive impair-
ment seems relatively minor in relation to the severity
of the behavioral disturbance. Consensus criteria have
been agreed that incorporate these elements and are
summarized below.
8
CLINICAL FEATURES OF LEWY-BODY DEMENTIA
￿ Progressive cognitive decline interfering with social or 
occupational functioning; memory loss may not be an 
early feature
￿ One or two features of:
- Fluctuating cognition with pronounced variation in 
attention and alertness
- Recurrent visual hallucinations
- Spontaneous motor features of parkinsonism
Assessment of 
dementia
The aim of investigations is to establish a diagnosis
and to detect the presence of coexisting disorders. An
accurate diagnosis makes appropriate discussion of
management and prognosis with the patient and their
family. A diagnosis of AD will arouse anxieties in fam-
ilies about the genetic implications. Differentiating
between AD and vascular dementia allows the clini-
cian to give the family information about the course of
the illness. 
The most important investigation is obtaining a full
history from the patient together with further infor-
mation from suitable informants such as family mem-
bers, and will include the family doctor who is an essen-
tial source of information about the patient’s family
history, past medical and personal history, premorbid
personality, social circumstances, and dynamics of fam-
ily relationships. 
Discussion with a reliable informant will quickly estab-
lish the onset and duration of the presenting problem.
Difficulties with memory and changes in personality are
universal. Problems encountered with hobbies, such as
following a complicated knitting pattern or playing
bridge, may be the first change noted. Knowledge of the
course of the illness is important in distinguishing vas-
cular dementia from AD. Evidence of psychotic symp-
toms such as hallucinations or delusions can be obtained
from family members. 
Examination of the mental state will show evidence of
any self-neglect, physical illness may be apparent, and
disinhibited or inappropriate behavior as might agita-
tion or retardation indicating depression. Guarded or
hostile behavior may indicate underlying paranoid
ideas. Poor attention span (indicating clouding of con-
sciousness) can be apparent and helpful in differenti-
ating delirium from dementia.
The patient’s speech will reveal evidence of aphasia or
dysarthria. Abnormalities of speech seen in advanced
dementia include perseveration (the patient continues
to give the answer to the previous question in response
to new questions), palilalia (when the last word of a
question is repeated with increasing frequency), logo-
clonia (when the last syllable is repeated), and logor-
rhea (a meaningless outpouring of words). The patient
may echo the examiner's speech (echolalia) or actions
(echopraxia). The content of thought is often impover-
ished in dementia, but careful questioning will reveal
the presence of delusions or depressive ideas and the
patient may elaborate on psychotic experiences.
Affective symptoms are often found in association with
dementia and may be the presenting feature—agitation,
anxiety, irritability are pointers. Disorders of perception
occur frequently in people with dementia, and features
suggestive of visual or auditory hallucinations will be
apparent from the history—it is not uncommon to see a
person hallucinating in the presence of the examiner.
Specific questioning will reveal psychotic symptoms such
as paranoid ideas or misidentifications.
MAIN FEATURES OF MENTAL STATE EXAMINATION
￿ Observe for agitation, retardation, self-neglect
￿ Enquire about symptoms of depression 
￿ Enquire about psychotic symptoms
￿ Observe any obvious manifestations of physical illness
￿ Carry out cognitive function tests
Assessment of cognitive function is greatly aided by
using a standard test such as the Mini-Mental State
Examination (MMSE).
9 The MMSE is scored out of 
30 points, of which 10 are given for orientation in time
and place and the remainder for tests of attention, 
registration, recall, language, manipulating informa-
tion, and praxis. It has been suggested that a cutoff of
23 or 24 on the MMSE is a satisfactory discriminator134
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between cognitive dysfunction and normality. The
MMSE is a useful screening instrument in clinical
assessment, but is not a substitute for a full history and
mental state examination. The MMSE is a useful screen
in patients referred with a possible dementia. It is quick
and easy to complete and sensitive to changes over
time, with an expected decline of approximately 3
points each year in a patient with AD.
A physical examination should be carried out with spe-
cific reference to the central nervous system. High blood
pressure and focal neurological signs indicate vascular
disease. Assessment of vision and hearing is important as
impairments may exaggerate cognitive dysfunction.
With regard to investigations, there are some that most
doctors would recognize as being essential and others
that depend on personal experience and, to a certain
extent, local availability. Debate surrounds which screen-
ing tests are necessary, and some people argue that the
low yield of treatable causes of dementia makes such
tests superfluous. Investigations that are most useful are
minimally invasive and relatively cheap. A standard
screen would include full blood count, erythrocyte sedi-
mentation rate, serum B12 and folate, urea and elec-
trolytes, liver function tests, thyroid function tests, and, if
there are atypical or unusual features, serological tests
for syphilis. More detailed investigation by a cardiolo-
gist or physician may be indicated in patients with cere-
brovascular disease in order to try and prevent further
strokes. Chest x-ray and an electrocardiogram are indi-
cated if suggested by abnormalities on clinical examina-
tion. Lumbar puncture is rarely carried out, but is indi-
cated if there is any evidence of infection or encephalitis.
Computed tomography scanning is the radiological
investigation of choice to exclude intracranial lesions,
with magnetic resonance imaging indicated for a more
detailed assessment of cerebral structures. Single pho-
ton emission computed tomography can reveal deficits in
blood flow and is particularly helpful in diagnosing
frontal lobe dementia. Electroencephalography is sensi-
tive to the confirmation of the diagnosis of delirium. 
Figure 1. Mini-Mental State (M.F. Folstein).
Reproduced from ref 9: Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the
clinician. J Psychiatr Res. 1975;12:189-198. Copyright © 1975, Elsevier Science Ltd. 135
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USEFUL INFORMATION FROM AN INFORMANT 
REGARDING DEMENTIA
￿ Onset of illness: gradual or sudden
￿ First symptoms
￿ Amount of social support
￿ Presence of psychotic symptoms
ASSESSMENT INSTRUMENTS USEFUL IN DEMENTIA
￿ Cognitive function
- Mini-Mental State Examination (MMSE)
- Clock Drawing Test
￿ Global assessment
- Clinical Dementia Rating
- Global Deterioration Scale 
￿ Psychiatric symptoms
- Cornell Scale for Depression in Dementia
- Neuropsychiatric Inventory
￿ Activities of daily living 
- Bristol Activities of Daily Living scale
- Disability Assessment of Dementia
Assessment instruments for dementia
A number of different instruments have been developed
to assess various aspects of dementia. A selection is sum-
marized below, with a more extensive range available
in Burns et al.
10
Cognitive function
￿ Mini-Mental State Examination (MMSE)
9: this is the
most widely used test of cognitive function. It is scored
out of 30, and tests the domains of orientation, language,
writing, memory, and praxis. It is reproduced in Table II.
￿ Standardized Mini-Mental State Examination (SMMSE)
11:
this is a standardized version of the Mini-Mental State
Examination, which comes with complete rating
instructions leading to slightly improved validity. 
￿ Abbreviated Mental Test Score (AMTS)
12 this is a much
briefer screening tool, scored out of 10, which tests
only orientation and memory.
￿ Alzheimer’s Disease Assessment Scale (ADAS)
13: this is
now a standard cognitive scale used in drug trials. It
assesses a number of cognitive functions includingClinical research
136
memory, language, and practice, and also has a section
devoted to noncognitive features.
￿ Clock Drawing Test (CDT)
14-16: this is a relatively new
development, is very easy to administer, and is very
popular in primary care because of its simplicity. 
Global measures
￿ Clinical Dementia Rating (CDR)
17,18: this is probably
the most widely used global scale to give an overall
severity rating in dementia, ranging from 0 (none),
0.5 (questionable dementia), through mild and mod-
erate to severe dementia. Each is rated in 6 domains:
memory, orientation, judgement and problem solv-
ing, community affairs, home and hobbies, and per-
sonal care.
￿ Global Deterioration Scale (CDS)
19: this consists of
the description of 7 stages of dementia from 1 (nor-
mal) to 7, where all verbal ability is lost. The scale
has been used extensively and validated with post-
mortem findings.
Psychopathology
￿ Cornell Scale for Depression in Dementia (CSDD)
20:
this is a 19-item scale, which specifically assesses depres-
sion in people with dementia in 5 main domains: mood-
related signs, behavioral disturbance, physical signs,
cyclic functions, and ideation disturbance. A mixture of
informant-rated and observational ratings makes it
ideal for the assessment in patients with cognitive
impairment where information from the patient might
not always be available. A score of 8 or above suggests
significant depressive symptoms.
￿ BEHAV-AD
21: this is a 25-item scale, which measures
many of the psychiatric symptoms and behavioral dis-
turbances associated with dementia. They are rated on
a 3-point scale, and a second part of the scale is a
global rating of the severity of the symptoms. the
BEHAV-AD is particularly useful in the assessement
of patients in drug trials.
￿ Neuropsychiatric Inventory (NPI)
22: 12 behavioral areas
are assessed in the NPI (delusions, hallucinations, agita-
tion, depression, anxiety, euphoria, apathy, disinhibition,
irritability, aberrant motor behavior, nighttime behav-
iors, and appetite/eating disorders), each of which is
rated on a 4-point scale of frequency and 3-point scale of
severity. Distress in carers is also measured.
￿ MOUSEPAD
23: this is based on the longer Present
Behavioral Examination and measures a number of
behavior and psychiatric symptoms, with particular
reference to their development over the life of the
dementia syndrome.
Functional ability
￿ Bristol Activities of Daily Living Scale (DADLS)
24:
this is a 20-item scale rated on a 5-point severity look-
ing at basic activities of daily living (eg, feeding, eating,
and toileting) and instrumental activities of daily living
(which refer to the performance of more complex
tasks such as shopping, traveling, answering the tele-
phone, and handling finances). 
￿ Interview for Deterioration in Daily living activities in
Dementia (IDDD)
25: this contains 33 self-care items
rated on a 4-point scale and has been used extensively
to assess the effects of drugs.
￿ Disability Assessment for Dementia (DAD)
26: a rat-
ing of activities of daily living in dementia separating
them into the different areas of initiation, planning
and organization, and affective performance; basic
activities and instrumental of activities daily living
are assessed.
￿ Alzheimer’s Disease Functional Assessment and
Change Scale (ADFACS)
27: this is an 18-item scale
looking at a wide range of basic activities and instru-
mental activities of daily living.
Conclusion
The initial assessment and investigation of a person with
dementia is particularly challenging and requires a sys-
tematic approach. It is a two-stage process, first with the
diagnosis of dementia, and second discovering the cause
of the dementia. Most information can be obtained by
simple observation and examination of the mental state,
and the major types of dementia can be delineated in
this way. It is usually necessary to perform a number of
relatively noninvasive investigations. There are a number
of standard scales that can be used in the documentation
of various features of dementia.   ❏Diagnosis and management of Alzheimer's disease - Burns Dialogues in Clinical Neuroscience - Vol 2 . No. 2 . 2000
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Diagnóstico y manejo de la enfer-
medad de Alzheimer
El diagnóstico de la Enfermedad de Alzheimer (EA) es un
proceso en dos etapas. En la primera etapa el síndrome
demencial se traducirá clínicamente en compromiso neurop-
sicológico y neuropsiquiátrico junto a los déficits en las acti-
vidades de la vida diaria y es posible diferenciarlo -en sus
manifestaciones clínicas- de muchas otras condiciones (deli-
rium, enfermedades físicas concomitantes, tratamientos
medicamentosos, pérdidas de memoria normales, etc.). En la
segunda etapa es posible determinar su causa; la EA es la
etiología más común, seguida por la demencia vascular, la
demencia por cuerpos de Lewy, la demencia del lóbulo fron-
tal y un conjunto de las así denominadas causas secundarias.
Aunque es común encontrar un cuadro en que se mezcla la
EA con causas vasculares, lo más típico de la EA es la apa-
rición gradual de los déficits cognitivos múltiples. En cam-
bio, la instalación brusca de los síntomas, un curso fluctuan-
te, hipertensión arterial y signos neurológicos focales son
más sugerentes de una demencia vascular. En la demencia
por cuerpos de Lewy la pérdida de memoria no aparece
necesariamente en la primera etapa y puede haber fluctua-
ciones, marcadas por síntomas psicóticos y trastornos de
conducta. Las investigaciones deberían ser mínimamante
invasoras y relativamente baratas, enfocadas a exámenes de
laboratorio de rutina, radiografías de tórax y/o electrocar-
diograma si existe alguna indicación clínica. En caso de pre-
sentarse signos cerebrovasculares se solicitará la evaluación
cardiológica o neurológica; la tomografía computarizada
cerebral se solicitará ante la sospecha de una lesión intracra-
neal. Un diagnóstico preciso de EA habilita al clínico para
delinear el curso de la enfermedad a los familiares e infor-
marles acerca de las implicancia genéticas. Además se revi-
san brevemente diversos instrumentos para evaluar la fun-
ción cognitiva, el estilo global, el bienestar psiquiátrico y las
actividades de la vida diaria. 
Diagnostic et prise en charge de la 
maladie d’Alzheimer
Le diagnostic de la maladie d’Alzheimer (MA) se fait en
deux étapes. En premier lieu, le diagnostic du syndrome de
démence, avec ses deux composantes neuropsychologique
et neuropsychiatrique, responsable de déficits dans les acti-
vités de la vie quotidienne, dont les caractéristiques cli-
niques permettent de le différencier d’autres pathologies
(délire, maladie concomitante, intoxication médicamenteu-
se, perte de mémoire banale, etc.). La seconde étape est
celle de la détermination de la cause, la plus fréquente étant
la MA, suivie par la démence vasculaire, la maladie des
corps de Lewy, la démence frontale et toute une série de
causes dites secondaires. Bien qu’un tableau mixte
Alzheimer/pathologie vasculaire soit fréquent, un début
progressif marqué par de multiples déficits cognitifs est
caractéristique de la MA, alors qu’un début brusque, un
déroulement fluctuant, une hypertension et des signes neu-
rologiques focaux sont en faveur d’une démence vasculai-
re. Dans la démence des corps de Lewy, la perte de mémoi-
re peut ne pas être précoce et les variations observées com-
portent des symptômes psychotiques sévères et des
troubles du comportement. On se limitera pour les investi-
gations à des examens peu invasifs et peu coûteux comme
des examens sanguins courants, une radio pulmonaire
et/ou un ECG selon la clinique, une consultation cardiolo-
gique ou neurologique en présence de signes cérébro-vas-
culaires et un scanner cérébral en cas de suspicion de
lésions intracrâniennes. Un diagnostic exact permet au
médecin d’informer la famille du déroulement prévisible
de la maladie et de ses implications génétiques. Nous pas-
serons brièvement en revue les nombreux tests qui permet-
tent d’évaluer la fonction cognitive, l’état général, l’état
mental et les activités de la vie quotidienne. 
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